Generation of reactive oxygen species and activation of NF-kappaB by non-Abeta component of Alzheimer's disease amyloid (Q44068698)

29 November 2017

title

Generation of reactive oxygen species and activation of NF-kappaB by non-Abeta component of Alzheimer's disease amyloid (English)

1 reference

29 November 2017

main subject

reactive oxygen species

1 reference

1 reference

1 reference

Eliezer Masliah

1 reference

29 November 2017

Seigo Tanaka

1 reference

29 November 2017

Masanori Takehashi

1 reference

29 November 2017

Naomi Matoh

1 reference

29 November 2017

Shinya Iida

1 reference

29 November 2017

Tomoki Suzuki

1 reference

29 November 2017

Shiroh Futaki

1 reference

29 November 2017

Hirofumi Hamada

1 reference

29 November 2017

Yukio Sugiura

1 reference

29 November 2017

Kunihiro Ueda

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

Journal of Neurochemistry

29 November 2017

published in

1 reference

29 November 2017

1 reference

29 November 2017

1 reference

29 November 2017

page(s)

305-315

1 reference

Amyloid beta protein inhibits cellular MTT reduction not by suppression of mitochondrial succinate dehydrogenase but by acceleration of MTT formazan exocytosis in cultured rat cortical astrocytes

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

The NF-kappaB/Rel family of proteins mediates Abeta-induced neurotoxicity and glial activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

Hydrogen peroxide mediates amyloid beta protein toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

Identification of the region of non-Abeta component (NAC) of Alzheimer's disease amyloid responsible for its aggregation and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

Activation of nuclear factor-κB by β-amyloid peptides and interferon-γ in murine microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

Production of superoxide anions by a CNS macrophage, the microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

Neurotoxicity of a prion protein fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

The role of NAC in amyloidogenesis in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

The biochemistry of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

alpha-synuclein promotes mitochondrial deficit and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

Non-A.beta. Component of Alzheimer's Disease Amyloid (NAC) is Amyloidogenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

Programmed cell death and Bcl-2 protection in very low oxygen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

Beta-amyloid (1-42) affects MTT reduction in astrocytes: implications for vesicular trafficking and cell functionality

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

Characterization of a neuronal kappaB-binding factor distinct from NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

NF-kappa B: a crucial transcription factor for glial and neuronal cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

Early association of reactive astrocytes with senile plaques in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

Glial cell diversification in the rat optic nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

Transgenic murine cortical neurons expressing human Bcl-2 exhibit increased resistance to amyloid beta-peptide neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

Iron accumulation in Alzheimer disease is a source of redox-generated free radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

Oxidative stress in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

Glial involvement in the degeneration process of Lewy body-bearing neurons and the degradation process of Lewy bodies in brains of dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer disease amyloid, binds A beta and stimulates A beta aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2002.00958.X

10.1046/J.1471-4159.2002.00958.X

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference